Given the dual nature of IL-6 in the development of atherosclerosis, it makessense to study other IL-6 signaling mediators as targets, which determine whetherthe IL-6 signal will go via the classical or trans-pathway. This evidence concerns the gene IL6 and atherosclerosis.